Catch the full moon rise over the southeastern horizon on June 10. Look up — or rather, down — tonight to spot the lowest ...

ESA has found a way to make its own solar eclipses more or less on demand and all it took was a pair of robotic spacecraft ...

Legendary NASA astronaut has expressed excitement for the appearance of a Strawberry Moon tonight, saying it will be the 'best lunar views in 20 years' ...

Intrepid Studios discusses plans and expectations in a roadmap update for Ashes of Creation Phase 3, showing The Anvils, ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorderBRAVE study will explore ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

In potential good news for Prothena, Roche announced earlier this week that it will advance Prothena-partnered prasinezumab into phase 3 trials for early-stage Parkinson’s disease, despite the ...

Biogen has initiated the BRAVE study, a global Phase 3 clinical trial to evaluate omaveloxolone in children with Friedreich ataxia, addressing a critical unmet need in the pediatric population.

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in ...

AbbVie (NYSE:ABBV) recently announced positive results from its Phase 3 TEMPLE study, marking significant progress in migraine treatment. Over the last month, AbbVie’s stock price remained ...

In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...